Bone Modifying Agents

Exploring the vital role of Bone Modifying Agents like bisphosphonates and Denosumab in reducing skeletal complications for cancer patients. Discussing the impact of breast, prostate, and lung cancers on bone metastasis. Stressing the importance of creatinine clearance cutoffs, dental clearance, and monitoring for side effects prior to treatment. Highlighting the efficacy of these agents in managing metastatic diseases and rare bone sarcomas.